Works by Gallipoli, Paolo

Results: 23

Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.

Published in:

2009

By:

Gallipoli, Paolo

Publication type:

Letter

The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.

Published in:

American Journal of Hematology, 2009, v. 84, n. 11, p. 750, doi. 10.1002/ajh.21498

By:

Gallipoli, Paolo;
Clark, Andrew;
Leach, Mike

Publication type:

Article

The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.665291

By:

Dembitz, Vilma;
Gallipoli, Paolo

Publication type:

Article

Laboratory and clinical risk assessment to treat myelodysplatic syndromes.

Published in:

Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 9, p. 1411, doi. 10.1515/cclm-2015-0789

By:

Gidaro, Antonio;
Deliliers, Giorgio Lambertenghi;
Gallipoli, Paolo;
Arquati, Massimo;
Wu, Maddalena Alessandra;
Castelli, Roberto

Publication type:

Article

Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient-derived xenografts.

Published in:

HemaSphere, 2024, v. 8, n. 1, p. 1, doi. 10.1002/hem3.28

By:

Dembitz, Vilma;
Durko, Jozef;
Campos, Joana;
James, Sophie C.;
Lawson, Hannah;
Kranc, Kamil R.;
Gallipoli, Paolo

Publication type:

Article

S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA.

Published in:

2023

By:

Dokal, Arran;
Borek, Weronika E.;
Nobre, Luis;
Federico Pedicona, Salvatore;
Wrench, Bela;
Gallipoli, Paolo;
Arruda, Andrea;
Campbell, Amy E.;
Nawaz, Nazrath;
Ferguson, Harriet R.;
Perkins, David N.;
Moreno-Cardoso, Pedro;
Thompson, Andrew;
Williamson, Andrew J.K.;
Minden, Mark D.;
Gribben, John G.;
Britton, David J.;
Cutillas, Pedro R.

Publication type:

Abstract

Safety and efficacy of pulsed imatinib with or without G- CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.

Published in:

British Journal of Haematology, 2013, v. 163, n. 5, p. 674, doi. 10.1111/bjh.12532

By:

Gallipoli, Paolo;
Stobo, Jon;
Heaney, Nicholas;
Nicolini, Franck E.;
Clark, Richard;
Wilson, George;
Tighe, Jane;
McLintock, Lorna;
Hughes, Timothy;
Michor, Franziska;
Paul, James;
Drummond, Mark;
Holyoake, Tessa L.

Publication type:

Article

Neutrophil-specific granule deficiency.

Published in:

British Journal of Haematology, 2013, v. 160, n. 6, p. 735, doi. 10.1111/bjh.12207

By:

McIlwaine, Louisa;
Parker, Anne;
Sandilands, Gavin;
Gallipoli, Paolo;
Leach, Mike

Publication type:

Article

Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.

Published in:

British Journal of Haematology, 2011, v. 155, n. 1, p. 128, doi. 10.1111/j.1365-2141.2011.08653.x

By:

Gallipoli, Paolo;
Shepherd, Pat;
Irvine, David;
Drummond, Mark;
Holyoake, Tessa

Publication type:

Article

Multiple splenic calcifications.

Published in:

2009

By:

Fyfe, Andrew J.;
Gallipoli, Paolo

Publication type:

Other

Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37652-0

By:

Woodley, Keith;
Dillingh, Laura S.;
Giotopoulos, George;
Madrigal, Pedro;
Rattigan, Kevin M.;
Philippe, Céline;
Dembitz, Vilma;
Magee, Aoife M. S.;
Asby, Ryan;
van de Lagemaat, Louie N.;
Mapperley, Christopher;
James, Sophie C.;
Prehn, Jochen H. M.;
Tzelepis, Konstantinos;
Rouault-Pierre, Kevin;
Vassiliou, George S.;
Kranc, Kamil R.;
Helgason, G. Vignir;
Huntly, Brian J. P.;
Gallipoli, Paolo

Publication type:

Article

Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function.

Published in:

Annals of Hematology, 2014, v. 93, n. 9, p. 1523, doi. 10.1007/s00277-014-2070-8

By:

Castelli, Roberto;
Deliliers, Giorgio;
Colombo, Riccardo;
Moreo, Guido;
Gallipoli, Paolo;
Pantaleo, Giuseppe

Publication type:

Article

Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.

Published in:

Journal of Thrombosis & Thrombolysis, 2019, v. 47, n. 1, p. 155, doi. 10.1007/s11239-018-1773-4

By:

Castelli, Roberto;
Gallipoli, Paolo;
Schiavon, Riccardo;
Teatini, Thomas;
Deliliers, Giorgio Lambertenghi;
Bergamaschini, Luigi

Publication type:

Article

High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation.

Published in:

Journal of Thrombosis & Thrombolysis, 2018, v. 45, n. 1, p. 106, doi. 10.1007/s11239-017-1566-1

By:

Castelli, Roberto;
Gallipoli, Paolo;
Schiavon, Riccardo;
Teatini, Thomas;
Deliliers, Giorgio Lambertenghi;
Bergamaschini, Luigi

Publication type:

Article

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Published in:

British Journal of Haematology, 2022, v. 196, n. 6, p. e55, doi. 10.1111/bjh.17961

By:

Gallipoli, Paolo;
Clark, Richard E.;
Byrne, Jenny;
Apperley, Jane F.;
Milojkovic, Dragana;
Foroni, Letizia;
Goldman, John M.;
O'Brien, Stephen

Publication type:

Article

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex.

Published in:

JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 6, p. 405, doi. 10.1093/jnci/djt006

By:

Min Chen;
Gallipoli, Paolo;
DeGeer, Donna;
Sloma, Ivan;
Forrest, Donna L.;
Chan, Matthew;
Lai, Damian;
Jorgensen, Heather;
Ringrose, Ashley;
Hui Mi Wang;
Lambie, Karen;
Nakamoto, Helen;
Kyi Min Saw;
Turhan, Ali;
Arlinghaus, Ralph;
Paul, James;
Stobo, Jon;
Barnett, Michael J.;
Eaves, Allen;
Eaves, Connie J.

Publication type:

Article

WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59969-8

By:

Duan, Shunlei;
Agger, Karl;
Messling, Jan-Erik;
Nishimura, Koutarou;
Han, Xuerui;
Peña-Rømer, Isabel;
Shliaha, Pavel;
Damhofer, Helene;
Douglas, Max;
Kohli, Manas;
Pal, Akos;
Asad, Yasmin;
Van Dyke, Aaron;
Reilly, Raquel;
Köchl, Robert;
Tybulewicz, Victor L. J.;
Hendrickson, Ronald C.;
Raynaud, Florence I.;
Gallipoli, Paolo;
Poulogiannis, George

Publication type:

Article

Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia.

Published in:

Therapeutic Advances in Hematology, 2015, v. 6, n. 3, p. 103, doi. 10.1177/2040620715577614

By:

Gallipoli, Paolo;
Giotopoulos, George;
Huntly, Brian J. P.

Publication type:

Article

Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia.

Published in:

Science Translational Medicine, 2023, v. 15, n. 685, p. 1, doi. 10.1126/scitranslmed.abn5135

By:

Mian, Syed A.;
Philippe, Céline;
Maniati, Eleni;
Protopapa, Pantelitsa;
Bergot, Tiffany;
Piganeau, Marion;
Nemkov, Travis;
Di Bella, Doriana;
Morales, Valle;
Finch, Andrew J.;
D'Alessandro, Angelo;
Bianchi, Katiuscia;
Wang, Jun;
Gallipoli, Paolo;
Kordasti, Shahram;
Kubasch, Anne Sophie;
Cross, Michael;
Platzbecker, Uwe;
Wiseman, Daniel H.;
Bonnet, Dominique

Publication type:

Article

Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study.

Published in:

2020

By:

Castelli, Roberto;
Bergamaschini, Luigi;
Teatini, Thomas;
Cilumbriello, Luca;
Schiavon, Riccardo;
Gallipoli, Paolo;
Deliliers, Giorgio Lambertenghi

Publication type:

journal article

Thrombosis and hemostatic abnormalities in hematological malignancies.

Published in:

2014

By:

Colombo, Riccardo;
Gallipoli, Paolo;
Castelli, Roberto

Publication type:

Journal Article

SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07620-0

By:

Tzelepis, Konstantinos;
De Braekeleer, Etienne;
Aspris, Demetrios;
Barbieri, Isaia;
Vijayabaskar, M. S.;
Liu, Wen-Hsin;
Gozdecka, Malgorzata;
Metzakopian, Emmanouil;
Toop, Hamish D.;
Dudek, Monika;
Robson, Samuel C.;
Hermida-Prado, Francisco;
Yang, Yu Hsuen;
Babaei-Jadidi, Roya;
Garyfallos, Dimitrios A.;
Ponstingl, Hannes;
Dias, Joao M. L.;
Gallipoli, Paolo;
Seiler, Michael;
Buonamici, Silvia

Publication type:

Article

Targeted therapy in haematological malignancies.

Published in:

Journal of Pathology, 2010, v. 220, n. 4, p. 404, doi. 10.1002/path.2669

By:

Hamilton, Ashley;
Gallipoli, Paolo;
Nicholson, Emma;
Holyoake, Tessa L

Publication type:

Article